Article

Covid-19 vaccine immunogenicity in people living with HIV-1

2021-08-13

Abstract excerpt

<h4>Introduction</h4> COVID-19 vaccine efficacy has been evaluated in large clinical trials and in real-world situation. Although they have proven to be very effective in the general population, little is known about their efficacy in immunocompromised patients. HIV-infected individuals’ response to vaccine may vary according to the type of vaccine and their level of immunosuppression. We evaluated immunogenicity...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d6e6a474-1764-5864-a951-6a3d3acfe77c
DOI: 10.1101/2021.08.13.456258

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Covid-19 vaccine immunogenicity in people living with HIV-1DOI 10.1101/2021.08.13.456258Read

SARS-CoV-2 mRNA Vaccine Induced Immune Responses in Men with HIV-1 and Impact on Proviral ReservoirsSemantic proximity Read

Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine in people living with HIV-1Semantic proximity Read

Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine in People Living with HIV-1Semantic proximity Read

Impact of SARS-CoV-2 vaccination on systemic immune responses in people living with HIVSemantic proximity Read

Immunogenicity and Safety of Inactivated SARS-CoV-2 Vaccine in People Living with HIV: A Cross-Sectional StudySemantic proximity Read

Dynamics of Temporal Immune Responses in Nonhuman Primates and Humans Immunized with COVID-19 VaccinesSemantic proximity Read

Repeated mRNA vaccination sequentially boosts SARS-CoV-2-specific CD8+ T cells in persons with previous COVID-19Semantic proximity Read

Predicting humoral responses to primary and booster SARS-CoV-2 mRNA vaccination in people living with HIV: a Machine Learning approachSemantic proximity Read

HIV/AIDS Vaccines: 2018.Semantic proximity Read

Immune Response and Reactogenicity After Immunization With a Suboptimal Two-Dose mRNA Vaccine Followed by a Full Vaccination With a Standard mRNA Vaccine Compared to a Prime-Boost Regimen of a Standard mRNA Vaccine: A Multicenter Cohort StudySemantic proximity Read

Safety and immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccineSemantic proximity Read

Preliminary Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.351 VariantSemantic proximity Read